1-3 of 3
Francisco Llamas-Gutierrez
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Axicabtagene Ciloleucel As Second-Line Therapy for Large B-Cell Lymphoma in Transplant-Ineligible Patients: Primary Analysis of Alycante, a Phase 2 Lysa Study

Roch Houot, Emmanuel Bachy, Guillaume Cartron, François-Xavier Gros, Franck Morschhauser, Lucie Oberic, Thomas Gastinne, Pierre Feugier, Remy Dulery, Catherine Thieblemont, Magalie Joris, Francisco Llamas-Gutierrez, Emmanuel Itti, Cedric Menard, Yassine Al-Tabaa, Clement Bailly, Marie-Helene Delfau, Camille Laurent, Francois Lemonnier
Journal: Blood
Blood (2022) 140 (Supplement 1): 410–411.
https://doi.org/10.1182/blood-2022-156626
Published: 2022
Journal Articles

PIM2 kinase has a pivotal role in plasmablast generation and plasma cell survival, opening up novel treatment options in myeloma

Marion Haas, Gersende Caron, Fabrice Chatonnet, Stéphane Manenti, Elina Alaterre, Julie Devin, Céline Delaloy, Giulia Bertolin, Roselyne Viel, Amandine Pignarre, Francisco Llamas-Gutierrez, Anne Marchalot, Olivier Decaux, Karin Tarte, Laurent Delpy, Jérôme Moreaux, Thierry Fest
Journal: Blood
Blood (2022) 139 (15): 2316–2337.
https://doi.org/10.1182/blood.2021014011
Published: 2022
Includes: Supplemental data
Journal Articles

Pan-HDAC Inhibitors May Restore PRDM1 Expression in Follicular Lymphoma

Thierry Fest, Fabienne Desmots-Loyer, Mikael Roussel, MD PhD, Celine Pangault, PhD, Cedric Pastoret, MD, Francisco Llamas-Gutierrez, Eric Guiheneuf, Valérie Camara-clayette, Thierry Lamy, Pr, MD PhD, Karin Tarte, PhD, Vincent Ribrag, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2848.
https://doi.org/10.1182/blood-2018-99-113269
Published: 2018